The 6 analysts offering 12-month price forecasts for Aquestive Therapeutics Inc have a median target of 13.50, with a high estimate of 32.00 and a low estimate of 7.00. The median estimate represents a +96.51% increase from the last price of 6.87.
The current consensus among 6 polled investment analysts is to Buy stock in Aquestive Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.51
Reporting Date Mar 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.